News & Updates

A primary care–based multicomponent intervention helps identify patients with antihypertensive medication nonadherence but does not result in improvements in adherence or blood pressure (BP), as reported in a study.

The use of single-pill combination (SPC) therapies can help in the prevention of cardiovascular disease (CVD) deaths, particularly in settings where uptake is currently low, suggests a study.

Midlife women with a history of gestational hypertension exhibit some signs of cerebral small vessel disease, according to a study.

Using beta-blockers early can prevent 1-year mortality in patients with acute myocardial injury (AMI), reveals a recent study.

Effective antiviral therapy is crucial for achieving sustained viral clearance and improving outcomes in patients with COVID-19, particularly among immunocompromised individuals.

At the recent ESCMID Global 2025 in Vienna, Austria, Ruth Mokgokong, a pharmacologist at Pfizer, UK, presented findings from the EPIC-IC trial, highlighting the benefits of an extended nirmatrelvir-ritonavir regimen in severely immunocompromised patients with symptomatic COVID-19.

Cannabis use increases the risk of major adverse cardiovascular events (MACE), as shown in a robust meta-analysis, raising serious questions about the assumptions that cannabis use poses little cardiovascular (CV) risk among users.